High dose Vitamin D supplementation may reduce ICU admission rates in Covid-19 patients
The recent global pandemic has gained a lot of interest, several clinical trials and studies are being conducted even after the pandemic to face the detrimental effects of the COVID-19 virus, researchers and physicians try to discover possible treatments to improve the outcome of their patients
A new study reports vitamin D supplementation was associated with reduced ICU admission and mechanical ventilation rates in patients with SARS-CoV-2 infection. However, vitamin D supplementation did not significantly affect mortality associated with SARS-CoV-2 infection. The study is published in Nutrients.
Vitamin D’s potential role in COVID-19 prevention and treatment has gained the limelight. Some studies have suggested that individuals with low levels of vitamin D may be at increased risk of severe illness from COVID-19.
A systematic review and meta-analysis were conducted to evaluate the efficacy of vitamin D supplementation in COVID-19, focusing on length of hospital stay (LOS), admission to the intensive care unit (ICU), and mortality.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.